Yael Flamand

The University of Texas MD Anderson Cancer Center

Also affiliated with ECOG-ACRIN Cancer Research Group, Dana-Farber Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 19 papers. Top paper: “Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).”.

Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6500

N/A

0.694DataRank · unranked

101 citations

Yael Flamand, Gregory S. Weinstein, Shuli Li, Harry Quon, Ranee Mehra +15 more

Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2

JCO Precision Oncology(2023)10.1200/po.22.00421

N/A

0.656DataRank · unranked

16 citations

Yael Flamand, Melissa Wilson, Jason J. Luke, Hussein A. Tawbi, Fangxin Hong +19 more

Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial

The Lancet Digital Health(2023)10.1016/s2589-7500(23)00046-8

N/A

0.648DataRank · unranked

74 citations

Jirapat Likitlersuang, Dennis Bontempi, Zezhong Ye, Sanjay Aneja, Richard L. Bakst +16 more

A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311

Oral Oncology(2020)10.1016/j.oraloncology.2020.104797

N/A

0.574DataRank · unranked

45 citations

Yael Flamand, F. Christopher Holsinger, Gregory S. Weinstein, Harry Quon, Ranee Mehra +28 more

Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6077

N/A

0.385DataRank · unranked

12 citations

Yael Flamand, Harry Quon, Joaquín J. García, Gregory S. Weinstein, Umamaheswar Duvvuri +12 more

Risk factors for T‐cell lymphopenia in frequent platelet donors: The BEST collaborative study

Transfusion(2023)10.1111/trf.17567

N/A

0.312DataRank · unranked

7 citations

Denese C. Marks, Yael Flamand, Jason P. Acker, Bethany L. Brown, Carly Olafson +8 more

Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-4085

N/A

0.292DataRank · unranked

6 citations

Yael Flamand, Derrick T. Lin, Christine H. Chung, Mark W. McDonald, Stella Flampouri +20 more

Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7018

N/A

0.203DataRank · unranked

2 citations

Yael Flamand, Naomi B. Haas, Anne O’Neill, Robert S. DiPaola, Pearl Subramanian +6 more

Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6036

N/A

0.165DataRank · unranked

2 citations

Yael Flamand, Harry Quon, Gregory S. Weinstein, Ranee Mehra, Joaquín J. García +11 more

Pretreatment clinical and genetic factors predict early post‐treatment mortality in fit AML patients following induction

American Journal of Hematology(2021)10.1002/ajh.26188

N/A

0DataRank · unranked

2 citations

Yael Flamand, Rahul S. Vedula, Jurjen Versluis, Anne Charles, Kevin Copson +6 more

Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad099

N/A

0DataRank · unranked

13 citations

Victoria Koch, Yael Flamand, Rahela Aziz‐Bose, Lenka Ilcisin, Ariana Valenzuela +11 more

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Blood Advances(2022)10.1182/bloodadvances.2021006166

N/A

0DataRank · unranked

25 citations

Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Mark G. Faber +16 more

A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305

European Journal of Cancer(2023)10.1016/j.ejca.2023.113509

N/A

0DataRank · unranked

1 citations

Yael Flamand, P. Savvides, Jennifer M. Johnson, Ioannis Vathiotis, Marshall Levine +4 more

Inequitable Poverty Exposures: A Subspecialty Opportunity to Address Disparities

Hospital Pediatrics(2024)10.1542/hpeds.2023-007482

N/A

0DataRank · unranked

5 citations

Puja J. Umaretiya, Victoria Koch, Yael Flamand, Rahela Aziz‐Bose, Lenka Ilcisin +13 more

Genome‐wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia

British Journal of Haematology(2024)10.1111/bjh.19696

N/A

0DataRank · unranked

0 citations

Ram Nambiar, Emily Schultz, Xinyu Gao, Shuyi Liang, Yael Flamand +15 more

A new prognostic model in patients with recurrent or metastatic head and neck cancer treated with chemotherapy: An analysis of ECOG-ACRIN E1305.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6026

N/A

0DataRank · unranked

0 citations

Yael Flamand, P. Savvides, Jennifer M. Johnson, Shuli Li, Arlene A. Forastiere +2 more

Mutational analysis of the mitochondrial tRNA genes and flanking regions in lymphocytes from long-term pediatric cancer survivors given doxorubicin chemotherapy for acute lymphoblastic leukemia

Cardio-Oncology(2025)10.1186/s40959-025-00396-5

N/A

0DataRank · unranked

0 citations

Neha Bansal, Salina Torres, Kristen E. Stevenson, Yael Flamand, Dale M. Walker +3 more

Prediction of Life-threatening and Disabling Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

medRxiv(2021)10.1101/2021.09.24.21263986

N/A

0DataRank · unranked

0 citations

Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Rahul S. Vedula +15 more

A phase II/III trial of chemotherapy plus cetuximab versus chemotherapy plus bevacizumab versus atezolizumab plus bevacizumab following progression on immune checkpoint inhibition in recurrent/metastatic head and neck cancers: ECOG-ACRIN EA3202.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps6098

N/A

0DataRank · unranked

5 citations

Yael Flamand, Jennifer M. Johnson, Jeffrey J. Ishizuka, Fenghai Duan, Mei Tang +4 more